[1] Willett CG, Clark JW. Update on combined-modality treatment options for pancreatic cancer. Oncology, 2003, 17(12):29-36.
[2] Earle CC, Agboola O, Maroun J, et al. The treatment of locally advanced pancreatic cancer:, a practice guideline. Can J Gastroenterol,2003, 17(3):161-167.
[3] Ling CC, Li WX, Anderson LL The relative biological effectiveness of I-125 and Pb-103. Int J Radiat Oncol Biol Phys, 1995, 32(2):373-378.
[4] Aird EG, Folkard M, Mayes CR, et al. A purpose-buih iodine-125 irradiation plaque for low dose rate low energy irradiation of cell lines in vitro. Br J Radiol, 2001, 74(877):56-61.
[5] Mastsui Y, Asano T, Kenmochi T, et al. Effects of carbon-ion beams on human pancreatic cancer cell line that differ in genetic status. Am J Clin Oncol, 2004, 27(1):24-28.
[6] Ghaneh P, Greenhalf W, Humphreys M, et al. Adenovirus-mediated transfer of p53 and p16(INK4a)resuhs in pancreatic cancer regression in vitro and vivo. Gene Ther, 2001, 8(3):199-208.
[7] Collis SJ, Schwaninger JM, Ntambi AJ, et al. Evasion of early cellular response mechanisms following low level radiation-induced DNA damage. J Biol Chem, 2004, 279(48):49624-49632.
[8] Nath R, Bongiorni P, Chen Z, et al. Development of a rat solid tumor model for continuous low-dose-rate irradiation studies using 125I and 103Pd sources. Brachytherapy, 2004, 3(3):159-172.
[9] 王俊杰,修典荣,冉维强.放射性粒子组织间近距离治疗肿瘤.第2版,北京:北京大学出版社,2004.177-192.
[10] Bodner WR, Hilaris BS, Mastoras DA. Radiation therapy in pancreatic cancer:current practice and future trends. J Clin Gastroenterol, 2000, 30(3):230-233.
[11] Joyce F, Burcharth F, Holm HH, et al. Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma. Int J Radiat Oncol Biol Phys, 1990, 19(4):1049-1052.